Subject: BICX Up Again New Report Out

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
BICX Up Again New Report Out
Hot Stock to WatchHot Stock to Watch

Company: BioCorRx Inc. (OTCQB: BICX)


Price: 0.10

Change (%): + 0.015 (17.65)

Volume: 717,678
BICX Chart

Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The 22 Billion Dollar Substance Abuse Treatment Market In The U.S.

NEW YORK, March 27, 2015 /PRNewswire/ - BioCorRx, Inc. (BICX) operating in Santa Ana, California is a healthcare solutions organization, which focuses solely on addiction treatment; the market for which is estimated at 22 billion dollars in the U.S. alone. The Company created a unique treatment program which includes the use of FDA-approved Naltrexone in a specially compounded form for outpatient surgical implantation. The Company has exclusive rights (excluding Australia and New Zealand) to the specially formulated Naltrexone implant. The treatment program also includes an outpatient coaching regimen in which patients receive psycho-social therapy and support for their alcohol or substance abuse addictions.

The Company has strategic partnerships in the pipeline in which it hopes to increase its assets. They recently issued a letter of understanding to acquire Trinity RX Solutions (owner of the specific Naltrexone implant formula used by the Company) and all of its formulas. The Company has exclusive perpetual rights to the implant, however they are in the process of obtaining ownership of the formula outright. Through licensing of its Start Fresh Program, the Company has also begun to plan the introduction of the program to wellness centers across America. A pilot program is planned to be introduced to five wellness centers, and upon successful completion, the Start Fresh Program will be made available to Physicians Business Solutions’ network of approximately 1000 medical centers nationwide via a definitive agreement recently executed with Myriad Medical Marketing.

On March 27, 2015 there was a press release issued by Small Cap IR that was not authorized by BioCorRx Inc. which contained some inaccurate disclosures which have been corrected within this press release. Shareholders and investors should not rely on anything in this earlier press release and should instead carefully review the accurate disclosures set forth above.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks